Navigation Links
Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
Date:1/8/2009

REHOVOT, Israel and JERSEY CITY, New Jersey, January 8 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), the leading developer of microRNA-based molecular diagnostics, announced today it has signed an exclusive distribution agreement with Teva Pharmaceutical Industries Ltd. Under the terms of the agreement Teva will offer Rosetta Genomics' miRview(TM) tests in Israel and Turkey. The terms of the deal were not disclosed.

"This is yet another important step in Rosetta Genomics' commercialization efforts," noted Ronen Tamir, Chief Commercialization Officer at Rosetta Genomics. "As Israel provided its citizens with health insurance under the National Health Law, it represents a very attractive market for us. Teva has gained unsurpassed experience in marketing and obtaining reimbursement for complex molecular tests in Israel, and we are very excited to be partnering with them on these important tests. We are also excited to have Teva distribute our tests in Turkey, a country with significant market potential."

Using microRNAs, a group of recently discovered non-coding genes found to be highly sensitive biomarkers, Rosetta Genomics has developed proprietary technologies which can be the basis for a wide range of diagnostic tests.

The following tests will be distributed by Teva Pharmaceuticals:

- miRview(TM) mets - This test can accurately identify the primary tumor site in patients presenting with metastatic cancer, as well in patients whose tumor has not been identified, and consequently been labeled Cancer of Unknown Primary (CUP). As metastases need to be treated according to their primary origin, accurate identification of the metastases' primary origin can be critical for determining appropriate treatment.Current diagnostic methods to identify the origin of a metastasis include a wide range of costly, time consuming, and at times inefficient tests. miRview(TM) mets
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...olo., Nov. 5 The endangered black-...stern U.S. This rare carnivore feeds on prairie d...ague and often entire population die-offs in towns...) has implemented a ferret breeding program and ha...ir formerly native habitat. Unfortunately, plague...
(Date:11/5/2009)...Nov. 5 Transgenomic, Inc...cial results for the quarter ended September 30, 2... in the tables that follow. ,, Third Quarter 2...,000 or $0.01 per share for the third quarter of 2... per share for the third quarter of 2008. ,, N...
(Date:11/5/2009)...f., Nov. 5 WaferGen Bios... developer of state-of-the-art genetic analysis sy...D. has joined the company,s Scientific Advisory Bo... commercializing novel molecular diagnostics for c... development of computational biology systems for ...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pro Rep...ovember 5, 2009 -- Professional Reprographics, Ora...ompany is pleased to present Brooke Sanders to the...cs/PR specialist. The addition of Brooke to the co...ithin Professional Reprographics., , ,Brooke bring...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...stem cell research to high-tech bicycles to an ide...Tommy Thomspson, Wisconsin Technology Network read...es they clicked on and read during the last three ...test edition of Wisconsin Technology Review ­...logy Network. , ,As in past reviews, we present t...
...ICAGO -- The summer of 2005 has come and gone and...summer. I just spent an incredible weekend enjoyin... in my hometown of Scarsdale (just outside of New ...asy at this reunion (no, its not what you think!)....ear (1969-1970), we had this phenomenal rock and b...
...son, Wis. - Companies that register for the Oct. ... seminar that will help them prepare to seek priva... level. , ,"Venture Readiness Tools for Commercia...within the larger conference at Madison ,s Monona ...or the full symposium may take part in the 8:30 a....
Other Biology Technology:Midwest large cap life science group strengthening in the third quarter 2Midwest large cap life science group strengthening in the third quarter 3Early Stage Symposium session will help emerging companies prepare for investors 2
(Date:11/4/2009)...Mass., Oct. 20 Aware, In...nd technology and biometrics software, today repor... September 30, 2009. ,, Michael Tzannes, Awar...arlier today, we announced an agreement to sell ou... a new fabless semiconductor company being spun ou...
(Date:11/4/2009)... Calif., Oct. 23 GenVault Corporat...anagement for genomic discovery, medicine and iden...D., GenVault,s President and CEO, will be presenti...on October 26th and 27th in La Jolla, CA. ,, Du...overview of the company together with recent custo...
(Date:11/4/2009)... Oct. 27 Global Rainmakers, Inc., ...ced R&D laboratory, today announced that the c...ed to actively commercialize its suite of technolo...ecurity offerings. ,, During the past four year...rs to develop and deploy a series of core--but exp...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 1Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 2Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 3Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 4Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning 48277 1Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning 48277 2Sabinsa Corporation Validates Safety of Garcinia Cambogia Extract in Light of Hydroxycut Warning 48277 3Got a Problem 3F Think About It Overnight 48276 1Got a Problem 3F Think About It Overnight 48276 2
...om researchers at Harvard Medical School and Massa...osed at the 13th European Cancer Conference (ECCO)...delivery is possible using nanoparticle-apatamer c... aptamers) are short DNA or RNA fragments that can... affinity; analogous to monoclonal antibodies. In ...
...existence to tiny microorganisms living in the oce... vital services these microbes perform for the pla...sed today by the American Academy of Microbiology,...arth,s Habitability. , "Since life most likely beg...osest living descendants of the original forms of ...
...t -- a single light box and the over-the-counter d... by resetting their circadian body clock before cr...ch being published in The Endocrine Society,s Jour...s treatment can also help those with delayed sleep...t results from a misalignment between a person,s i...
Other Biology News:Researchers use 'trickery' to create immune response against melanoma 2Researchers use 'trickery' to create immune response against melanoma 3Researchers use 'trickery' to create immune response against melanoma 4Understanding the oceans microbes is key to the Earth's future 2Travelers can avoid jet lag by resetting their body clocks 2Travelers can avoid jet lag by resetting their body clocks 3
...onoclonal [198C679.2.1] to Presenilin 2 Alzheimer... the disease carry mutations in the presenilin pro...ein (APP). These disease-linked mutations result i...id-beta (main component of amyloid deposits found ...
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Goat Anti-Human Glypican 2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Beta 2-Microglobulin ELISA Kit from Biomeda Corporation
Biology Products: